Jarrod Walsh
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Mass Spectrometry Techniques and Applications, RNA and protein synthesis mechanisms, Cancer, Hypoxia, and Metabolism, Chemical Synthesis and Analysis
Most-Cited Works
- → Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis(2017)124 cited
- → Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily(2017)85 cited
- → Nuisance compounds in cellular assays(2021)61 cited
- → Affinity selection mass spectrometry speeding drug discovery(2023)38 cited
- → Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells(2016)38 cited
- → Identification of Compounds That Interfere with High‐Throughput Screening Assay Technologies(2019)34 cited
- → Nonspecific esterases of leukemia cell lines: evidence for activation of myeloid-associated zymogens in HL-60 by phorbol esters(1984)21 cited
- → A High-Throughput Screening Triage Workflow to Authenticate a Novel Series of PFKFB3 Inhibitors(2017)14 cited
- → Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor Immunity(2023)13 cited
- → Utility of Resazurin, Horseradish Peroxidase, and NMR Assays to Identify Redox-Related False-Positive Behavior in High-Throughput Screens(2018)13 cited